Financial statements Ipharm Press
Balance sheet data of IPHARM PRESS
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 13 459,79 | 19 945,01 | 9 645,13 | 6 276,59 | 17 224,66 | 14 408,67 |
A. Fixed assets | 1 000,00 | 1 000,00 | 1 000,00 | 1 000,00 | 1 000,00 | 1 000,00 |
B. Current assets | 12 459,79 | 18 945,01 | 8 645,13 | 5 276,59 | 16 224,66 | 13 408,67 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | - | - | - | - |
D. Own shares (stocks) | 0,00 | 0,00 | - | - | - | - |
Total liabilities | 13 459,79 | 19 945,01 | 9 645,13 | 6 276,59 | 17 224,66 | 14 408,67 |
A. Equity | 4 413,86 | 5 581,69 | 1 035,13 | -2 015,47 | 3 600,53 | 9 033,53 |
B. Liabilities and provisions for liabilities | 9 045,93 | 14 363,32 | 8 610,00 | 8 292,06 | 13 624,13 | 5 375,14 |
I. Long-term liabilities | 0,00 | - | - | - | - | - |
II. Short-term liabilities | 9 045,93 | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.